Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and effectiveness of tofacitinib in ulcerative colitis: Data from TOFA-UC, a SN-IBD study.
Macaluso FS, D'Antonio E, Fries W, Viola A, Ksissa O, Cappello M, Muscarella S, Belluardo N, Giangreco E, Mocciaro F, Di Mitri R, Ferracane C, Vitello A, Grova M, Renna S, Casà A, De Vivo S, Ventimiglia M, Orlando A; Sicilian Network for Inflammatory Bowel Disease (SN-IBD). Macaluso FS, et al. Among authors: mocciaro f. Dig Liver Dis. 2024 Jan;56(1):15-20. doi: 10.1016/j.dld.2023.08.061. Epub 2023 Sep 22. Dig Liver Dis. 2024. PMID: 37741749
Meta-analysis of trials for variceal bleeding.
D'amico G, Criscuoli V, Fili D, Mocciaro F, Pagliaro L. D'amico G, et al. Among authors: mocciaro f. Hepatology. 2002 Oct;36(4 Pt 1):1023-4; author reply 1024-5. doi: 10.1053/jhep.2002.34737. Hepatology. 2002. PMID: 12297857 No abstract available.
Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use.
Danese S, Mocciaro F, Guidi L, Scribano ML, Comberlato M, Annese V, Colombo E, Stefanelli T, Marzo M, Vangeli M, Pulitano' R, Manca A, Armuzzi A, Malesci A, Prantera C, Cottone M. Danese S, et al. Among authors: mocciaro f. Inflamm Bowel Dis. 2008 Aug;14(8):1168-70. doi: 10.1002/ibd.20426. Inflamm Bowel Dis. 2008. PMID: 18357580 Clinical Trial. No abstract available.
Adalimumab induction for Crohn's disease.
Cottone M, Mocciaro F, Scimeca D. Cottone M, et al. Among authors: mocciaro f. Gastroenterology. 2006 May;130(6):1929. doi: 10.1053/j.gastro.2006.03.051. Gastroenterology. 2006. PMID: 16697762 Clinical Trial. No abstract available.
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study.
Orlando A, Colombo E, Kohn A, Biancone L, Rizzello F, Viscido A, Sostegni R, Benazzato L, Castiglione F, Papi C, Meucci G, Riegler G, Mocciaro F, Cassinotti A, Cosintino R, Geremia A, Morselli C, Angelucci E, Lavagna A, Rispo A, Bossa F, Scimeca D, Cottone M; Italian Multicentric Study Group on Infliximab. Orlando A, et al. Among authors: mocciaro f. Dig Liver Dis. 2005 Aug;37(8):577-83. doi: 10.1016/j.dld.2005.01.019. Dig Liver Dis. 2005. PMID: 15886081 Clinical Trial.
Incidence of Crohn's disease and CARD15 mutation in a small township in Sicily.
Cottone M, Renda MC, Mattaliano A, Oliva L, Fries W, Criscuoli V, Modesto I, Scimeca D, Maggio A, Casà A, Maisano S, Mocciaro F, Sferrazza A, Orlando A. Cottone M, et al. Among authors: mocciaro f. Eur J Epidemiol. 2006;21(12):887-92. doi: 10.1007/s10654-006-9054-5. Epub 2006 Dec 8. Eur J Epidemiol. 2006. PMID: 17160430
110 results